Cargando…
Amplification of WHSC1L1 regulates expression and estrogen‐independent activation of ERα in SUM‐44 breast cancer cells and is associated with ERα over‐expression in breast cancer
The 8p11‐p12 amplicon occurs in approximately 15% of breast cancers in aggressive luminal B‐type tumors. Previously, we identified WHSC1L1 as a driving oncogene from this region. Here, we demonstrate that over‐expression of WHSC1L1 is linked to over‐expression of ERα in SUM‐44 breast cancer cells an...
Autores principales: | Irish, Jonathan C., Mills, Jamie N., Turner-Ivey, Brittany, Wilson, Robert C., Guest, Stephen T., Rutkovsky, Alexandria, Dombkowski, Alan, Kappler, Christiana S., Hardiman, Gary, Ethier, Stephen P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920706/ https://www.ncbi.nlm.nih.gov/pubmed/27005559 http://dx.doi.org/10.1016/j.molonc.2016.02.003 |
Ejemplares similares
-
Oncogenic signaling in amphiregulin and EGFR‐expressing PTEN‐null human breast cancer
por: Kappler, Christiana S., et al.
Publicado: (2014) -
KAT6A, a Chromatin Modifier from the 8p11-p12 Amplicon is a Candidate Oncogene in Luminal Breast Cancer
por: Turner-Ivey, Brittany, et al.
Publicado: (2014) -
Development and implementation of the SUM breast cancer cell line functional genomics knowledge base
por: Ethier, Stephen P., et al.
Publicado: (2020) -
Protein Kinase CK2 Expression Predicts Relapse Survival in ERα Dependent Breast Cancer, and Modulates ERα Expression in Vitro
por: Williams, Marlon D., et al.
Publicado: (2015) -
The correlation between DNMT1 and ERα expression and the methylation status of ERα, and its clinical significance in breast cancer
por: ZHANG, WEIJIE, et al.
Publicado: (2016)